Parabilis Medicines Quarterly Cash Flow Statement
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.48-0.61 (-2.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Parabilis Medicines cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | -52.46M | -45.32M | -34.81M | -38.33M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 600.00K | — | 200.00K | — |
| Stock-Based Compensation | 3.63M | — | 823.00K | — |
This table shows 4 quarterly periods of Parabilis Medicines's cash flow statement, from Q2 2026 back to Q? 2025, across 3 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PBLS's reporting calendar. What is a cash flow statement?